Martin Samuel Bates - Insider Non-Derivative Transactions at Celldex Therapeutics, Inc. (CLDX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 14, 2024, Martin Samuel Bates's relationship to Celldex Therapeutics, Inc. (CLDX) is Officer (SVP AND CFO), and currently has 45,297 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CLDX insiders.
Data Source: SEC.
Martin Samuel Bates - Insider Non-Derivative Transactions of CLDX Common Stock
Martin Samuel Bates - Insider Non-Derivative Transactions at CLDX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 15, 2024 | Sell -- (Common Stock) | 17172 | 35.42 | 28125 |
| Jun 15, 2024 | M -- (Common Stock) | 3201 | 9.02 | 28329 |
| Jun 15, 2024 | M -- (Common Stock) | 16968 | 10.38 | 45297 |
| May 31, 2024 | Sell -- (Common Stock) | 35000 | 34.05 | 25128 |
| May 31, 2024 | M -- (Common Stock) | 25000 | 10.38 | 60128 |
| Jan 3, 2024 | M -- (Common Stock) | 10750 | 2.78 | 35128 |